Bioinformatics research on the SARS coronavirus (SARS_CoV) in China

Current Pharmaceutical Design

Volumn 12, Issue 35, 2006, Pages 4565-4572

  Hao, Pei ^a,b   Chen, Min ^a   Zhang, Guoqing ^a,c   He, Weizhong ^a   Li, Yixue ^a,b  

^a SHANGHAI CENTER FOR BIOINFORMATION TECHNOLOGY   (China)

^b Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

^c HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Functional genomics; Molecular evolution; SARS; SARS_CoV; Transmission model

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; ANTIVIRUS AGENT; CYCLOPHILIN A; CYSTEINE PROTEINASE; MEMBRANE PROTEIN; NUCLEOCAPSID PROTEIN; SEVERE ACUTE RESPIRATORY SYNDROME VACCINE; VIRUS ENVELOPE PROTEIN; VIRUS SPIKE PROTEIN;

ACCESS TO INFORMATION; BIOINFORMATICS; CHINA; CODON; COMPUTER PROGRAM; DISEASE TRANSMISSION; DRUG DESIGN; EPIDEMIC; FATALITY; FUNCTIONAL GENOMICS; GENE MUTATION; GENE SEQUENCE; GENETIC VARIABILITY; HONG KONG; HUMAN; INCIDENCE; INTERNET; MATHEMATICAL MODEL; MEDICAL RESEARCH; NONHUMAN; OPEN READING FRAME; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN INTERACTION; PROTEIN SECONDARY STRUCTURE; REVIEW; RNA INTERFERENCE; SARS CORONAVIRUS; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS; SEVERE ACUTE RESPIRATORY SYNDROME; THEORETICAL MODEL; VIRUS GENE; VIRUS IDENTIFICATION; VIRUS ISOLATION; VIRUS TRANSMISSION;

CHINA; COMPUTATIONAL BIOLOGY; DISEASE OUTBREAKS; EVOLUTION, MOLECULAR; GENOME, VIRAL; HONG KONG; HUMANS; LOGISTIC MODELS; SARS VIRUS; SEVERE ACUTE RESPIRATORY SYNDROME;

EID: 33751534833     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/138161206779010404     Document Type: Review

References (56)

1. Drosten C, Preiser W, Gunther S, Schmitz H, Doerr HW. Severe acute respiratory syndrome: identification of the etiological agent. Trends Mol Med 2003; 9: 325-327.
2. Ksiazek TG, Erdman D, Goldsmith CS, Zaki SR, Peret T, Emery S. A novel coronavirus associated with severe acute respiratory syndrome. N Eng J Med 2003; 348: 1953-1966.
3. Poon LL, Guan Y, Nicholls JM, Yuen KY, Peiris JS. The aetiology, origins, and diagnosis of severe acute respiratory syndrome. Lancet Infect Dis 2004; 4: 663-671.
4. Enserink M. SARS in China. China's missed chance. Science 2003; 301: 294-296.
5. Marra MA, Jones SJ, Astell CR, Holt RA, Brooks-Wilson A, Butterfield YS. The Genome sequence of the SARS-associated coronavirus. Science 2003; 300: 1399-1404.
6. Qin E, He X, Tian W, Liu Y, Li W, Wen J. A complete sequence and comparative analysis of a SARS-associated Virus Isolate BJ01. Chinese Sci Bull 2003; 48: 941-948.
7. Qin E, He X, Tian W, Liu Y, Li W, Wen J. A genome sequence of novel SARS-CoV isolates: the genotype, GD-Ins29, leads to a hypothesis of viral transmission in South China. Genomics Proteomics Bioinformatics 2003; 1: 101-107.
8. Bi S, Qin E, Xu Z, Li W, Wang J, Hu Y. Complete genome sequences of the SARS-CoV: the BJ Group (Isolates BJ01-BJ04). Genomics Proteomics Bioinformatics 2003; 1: 180-192.
9. Chen TG, Wu SF, Wan P, Du CJ, Li JQ, Li D. Gene prediction and function research of SARS-CoV(BJ01). Yi Chuan Xue Bao 2003; 30: 773-780.
10. Salamov AA, Nishikawa T, Swindells MB. Assessing protein coding region integrity in cDNA sequencing projects. Bioinformatics 1998: 14: 384-390.
11. Kozak M. An analysis of 5′-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res 1987; 15: 8125-8148.
12. Liu SQ, Guo T, Ji XL, Sun ZR. Bioinformatical study on the proteomics and evolution of SARS_CoV. Chin Sci Bull 2003; 48: 1277-1281.
13. Guo FB, Ou HY, Zhang CT. ZCURVE: a new system for recognizing protein-coding genes in bacterial and archaeal genomes. Nucleic Acids Res 2003; 31: 1780-1789.
14. Chen LL, Ou HY, Zhang R, Zhang CT. ZCURVE_CoV: a new system to recognize protein coding genes in coronavirus genomes, and its applications in analyzing SARS-CoV genomes. Biochem Biophys Res Commun 2003; 307: 382-388.
15. Gao F, Ou HY, Chen LL, Zheng WX, Zhang CT. Prediction of proteinase cleavage sites in polyproteins of coronaviruses and its applications in analyzing SARS-CoV genomes. FEBS Lett 2003; 553: 451-456.
16. Bateman A, Coin L, Durbin R, Finn RD, Hollich V, Griffiths-Jones S. The Pfam protein families database. Nucleic Acids Res 2004; 32: D138-D141.
17. Henikoff JG, Greene EA, Pietrokovski S, Henikoff S. Increased coverage of protein families with the blocks database servers. Nucleic Acids Res 2000; 28: 228-230.
18. McGuffin LJ, Bryson K, Jones DT. The PSIPRED protein structure prediction server. Bioinformatics 2000; 16: 404-405.
19. Persson B, Argos P. Prediction of transmembrane segments in proteins utilising multiple sequence alignments. J Mol Biol 1994; 237: 182-192.
20. Sonnhammer EL, von Heijne G, Krogh A. A hidden Markov model for predicting transmembrane helices in protein sequences. Proc Int Conf Intell Sys Mol Biol 1998; 6: 175-182.
21. Nakai K, Horton P. PSORT: a program for detecting sorting signals in proteins and predicting their subcellular localization. Trends Biochem Sci 1999; 24: 34-36.
22. Brendel V, Bucher P, Nourbakhsh IR, Blaisdell BE, Karlin S. Methods and algorithms for statistical analysis of protein sequences. Proc Natl Acad Sci USA 1992; 89: 2002-2006.
23. Subramaniam S. The Biology Workbench - a seamless database and analysis environment for the biologist. Proteins 1998; 32: 1-2.
24. Xu ZY, Zhang HQ, Tian XJ, Ji J, Yang HM. The R Protein of SARS_CoV: Analysis of Structure and Function Based on Four Complete Genome Sequences of Isolates BJ01-BJ04. Genomics Proteomics Bioinformatics 2003; 1: 156-165.
25. Rota PA, Oberste MS, Monroe SS, Nix WA, Campagnoli R, Icenogle JP. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 2003; 300: 1394-1399.
26. Qin L, Xiong B, Luo C, Guo ZM, Hao P, Su J. Identification of probable genomic packaging signal sequence from SARS-CoV genome by bioinformatics analysis. Acta Pharm Sin 2003; 24: 489-496.
27. Shiang R. Vector NTI Suite v5.5.1. Biotech Software & Internet Report 2000; I: 214-219.
28. Mathews DH, Sabina J, Zuker M, Turner DH. Expanded sequence dependence of thermodynamic parameters improves prediction of RNA secondary structure. J Mol Biol 1999; 288: 911-940.
29. Kyte J, Doolittle RF. A simple method for displaying the hydropathic character of a protein. J Mol Biol 198; 157: 105-132.
30. Emini EA, Hughes JV, Perlow DS, Boger J. Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide. J Virol 1985; 55: 836-839.
31. Jameson BA, Wolf H. The antigenic index: a novel algorithm for predicting antigenic determinants. Comput Appl Biosci 1988; 4: 181-186.
32. Li WJ, Fan M. Prediction of the epitopes of SARS_CoV. Med J Chin PLA 2003; 28: 9-12.
33. He F, Zhao W, Long BG, Jian LF. Comparison of E,M genome sequence of SARS_CoV and prediction of related B cell epitopes. Prog Microbiol Immu 2004; 32: 10-14.
34. Lv YB, Wu YZ. Prediction of the Secondary Structure and B Cell Epitopes for the M Protein of SARS Coronavirus. China Biotech 2003; 23: 41-45.
35. Wang Q, Wu YZ. Prediction of HLA-A* 0201-restricted CTL epitopes in SARS_CoV N protein. Immunol J 2004; 20: 86-95.
36. Yu XJ, Luo C, Lin JC, Hao P, He YY, Guo ZM. Putative hAPN receptor binding sites in SARS_CoV spike protein. Acta Pharm Sin 2003; 24: 481-488.
37. Luo C, Luo H, Zheng S, Gui C, Yue L, Yu C. Nucleocapsid protein of SARS coronavirus tightly binds to human cyclophilin A. Biochem Biophys Res Commun 2004; 321: 557-565.
38. Yu XJ, Lin JC, Chen M, Shi TL, Li YX. A Novel Domain-based Method to Predict the Functional Classes of Proteins. Chinese Sci Bull 2004; 49: 2379-2384.
39. Yu C, Gui C, Luo H, Chen L, Zhang L, Yu H. Folding of the SARS coronavirus spike glycoprotein immunological fragment (SARS_S1b): thermodynamic and kinetic investigation correlating with three-dimensional structural modeling. Biochemistry 2005; 44: 1453-1463.
40. McDonald IK, Thornton JM. Satisfying hydrogen bonding potential in proteins. J Mol Biol 1994; 238: 777-793.
41. Chinese Sars Molecular Epidemiology Consortium. Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China. Science 2004; 303: 1666-1669.
42. Pamilo P, Bianchi NO. Evolution of the Zfx and Zfy genes: rates and interdependence between the genes. Mol Biol Evol 1993; 10: 271-281.
43. Li WH. Unbiased estimation of the rates of synonymous and nonsynonymous substitution. J Mol Evol 1993; 36: 96-99.
44. Song HD, Tu CC, Zhang GW, Wang SY, Zheng K, Lei LC. Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human. Proc Natl Acad Sci USA 2005; 102: 2430-2435.
45. Zheng Q. The analysis of SARS_CoV based on comparative genome. Chinese Sci Bull 2003; 48: 12-12.
46. Lu H, Zhao Y, Zhang J, Wang Y, Li W, Zhu X. Date of origin of the SARS coronavirus strains. BMC Infect Dis 2004; 4: 3-3.
47. Wang Y, Ma WL, Zheng WL. Analysis of SARS Coronavirus' Codon Preference. Life Sci Res (Seppl) 2003; 7: 219-223.
48. Wang Q, Li G, Li BJ. Dinucleotide Signature Analysis of the Genome of SARS Coronavirus. Chinese J Vir 2004; 20: 79-80.
49. Zheng L, Xi C, Hu T, Long XZ. Infectious Kinetics of SARS Epidemic. Prog Biochem Biophys 2004; 31: 167-171.
50. Huang DS, Guan P, Zhou BS. Fitness of morbidity and discussion of epidemic characteristics of SARS based on logistic model. Chinese J Public Health 2003; 19: 1-2.
51. Chen QZ. Application of SIR Model in forecasting and analyzing for SARS. J Peking Univ (Health Sci) 2003; 35: 75-80.
52. Huang DS, Guan P, Zhou BS. Research on fitting of SIR model on prevalence of SARS in Beijing city. Chinese J Dis Contl Prev 2004; 8: 398-401.
53. Chen Q. Application of SIR model in forecasting and analyzing for SARS. Beijing Da Xue Xue Bao 2003; 35(Suppl): 75-80.
54. Alper O, Bowden ET. Novel insights into c-Src. Curr Pharm Des 2005; 11(9): 1119-30.
55. Altmeyer R. Virus attachment and entry offer numerous targets for antiviral therapy. Curr Pharm Des 2004; 10(30): 3701-12.
56. Kantardjieff K, Rupp B. Structural bioinformatic approaches to the discovery of new antimycobacterial drugs. Curr Pharm Des 2004; 10(26): 3195-211.